Skip to main content
Premium Trial:

Request an Annual Quote

Immucor, Pirche Partner to Embed Epitope Matching Prediction Pipeline into Transplant Dx Software

NEW YORK – Transfusion and transplantation diagnostics company Immucor said Tuesday that it has invested an undisclosed amount in German molecular matching and predictive analytics firm Pirche as part of a new partnership to expand the capabilities of its own software.

As part of the partnership, Norcross, Georgia-based Immucor will receive exclusive access to Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) scores and embedded visualizations for antibody analysis. This will give Immucor customers a direct interface to Berlin-based Pirche's artificial intelligence-driven epitope matching prediction pipeline. 

"The establishment of our partnership with Pirche will allow transplant histocompatibility laboratories the option to integrate their data with PIRCHE [scores] easily," Immucor President and CEO Avi Pelossof said in a statement.

Immucor Chief Marketing Officer Christie Otis said that the partnership gives the firm the chance to "provide a unique offering" to laboratories of single-antigen results through the firm's Lifecodes LSA assays, HLA typing results from Immucor's Lifecodes HLA SSO typing kits, and Mia Fora NGS kits. The addition of PIRCHE-II and Pirche-Snowflake scores to Immucor's software also facilitates seamless calculation of T-cell and B-cell epitope matching.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.